Location History:
- Dusseldorf, DE (1998 - 1999)
- D{umlaut over (u)}sseldorf, DE (2001)
Company Filing History:
Years Active: 1998-2001
Title: Georg Terstappen: Innovator in Pharmaceutical Chemistry
Introduction
Georg Terstappen is a prominent inventor based in Düsseldorf, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on the development of innovative compounds that have potential applications in drug formulation.
Latest Patents
Among his latest patents, Terstappen has developed bis-(quinolyl)-diamines, which are characterized by a specific general formula. This invention relates to compounds that can be utilized in various pharmaceutical applications. Additionally, he has patented 2,2'-bridged bis-2,4-diaminoquinazolines, which also follow a defined general formula. These compounds are significant for their potential use in drug preparation and the formulation of new therapeutic agents.
Career Highlights
Georg Terstappen is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to explore innovative solutions in drug development, contributing to the advancement of medical science.
Collaborations
Throughout his career, Terstappen has collaborated with notable colleagues, including Rudolf Schohe-Loop and Peter-Rudolf Seidel. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.
Conclusion
Georg Terstappen's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new drugs and therapeutic solutions.